Home/Filings/4/0001061983-26-000001
4//SEC Filing

Callos Andrew 4

Accession 0001061983-26-000001

CIK 0001061983other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 6:01 PM ET

Size

9.3 KB

Accession

0001061983-26-000001

Insider Transaction Report

Form 4
Period: 2026-01-02
Callos Andrew
EVP, Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2026-01-02$62.09/sh913$56,68850,440 total
  • Exercise/Conversion

    Common Stock

    2026-01-02$37.63/sh+885$33,30351,325 total
  • Sale

    Common Stock

    2026-01-02$63.16/sh885$55,89750,440 total
  • Exercise/Conversion

    Incentive Stock Option (Right to Buy)

    2026-01-028851,772 total
    Exercise: $37.63From: 2025-04-01Exp: 2032-03-01Common Stock (885 underlying)

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeother

Related Parties

1
  • filerCIK 0001852129

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 6:01 PM ET
Size
9.3 KB